MedTrace Logo

A Sample Collection Study to Validate the NEPHROCLEAR™ CCL14 Test

NCT04785391 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-07-20

No results posted yet for this study

Summary

The objective of this sample collection study is to collect urine samples to validate the NEPHROCLEAR™ CCL14 Test in patients with KDIGO stage 2 or 3 AKI. This study is observational and will have no impact on the medical management of the subject.

Conditions

Interventions

DIAGNOSTIC_TEST

Urine collection for NEPHROCLEAR CCL14 Test

Urine will be collected and banked for future analysis with the NEPHROCLEAR CCL14 Test

Sponsors & Collaborators

  • Astute Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Jay L Koyner, MD · University of Chicago

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-08
Primary Completion
2022-12-31
Completion
2022-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04785391 on ClinicalTrials.gov